• arclein
Surinder Soond, who worked on the study, said it was a "novel and exciting approach to treating cancer and the spread of tumours which holds great potential".
"The challenge now is to identify a potent drug that will get inside cancer cells and destroy the activity of the rogue gene," said Andrew Chantry of UEA's school of biological sciences, who led the research.